Conference Recordings

  • 11 CME/CE

    CME/CE Expiration Date: 05/21/2025* 

    Highly experienced obesity medicine clinicians can attend advanced level sessions during the Masters Track that will build upon established experience in obesity medicine. These advanced level sessions are more specialized in nature and allow the learner to integrate and enhance new knowledge and skills into their practice. Attendees will be sitting in rounds with participation in polling and interactive discussions being encouraged. Presentations will focus on case-based, real life studies that will challenge your knowledge of obesity medicine and help advance your understanding of the disease and treatment strategies to the next level. 

    Sessions during this track will focus on: 

    • Discussing the association between nutrition and cancer 
    • Prescriptive nutritional intervention using meal replacements 
    • Discussing various patient cases on obesity and adiposity-related diseases  
    • Future advances on anti-obesity medications in development 
    • Multidisciplinary panel discussion on complex patients 
    • Physical Limitations and Obesity  

    Accreditation: 

    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this enduring activity for a maximum of 11.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Includes Credits

    Andres Acosta, MD, PhD

    CME/CE Expiration Date: 5/21/2025* 

    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

    Description: 

    There is a marked variation in individual patient response to interventions designed to treat obesity and adiposity related diseases. The heterogenicity in obesity treatment response is not surprising when considering the numerous underlying factors that contribute to adiposity and associated conditions. This session will use case presentations to demonstrate how identifying patient phenotypic subgroups when choosing an anti-obesity agent, can improve clinical outcomes in patients treated for obesity.

    Accreditation: 

    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Includes Credits

    Angela Fitch, MD

    CME/CE Expiration Date: 5/21/2025* 

    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

    Description: 

    Learn the evidence for use of meal replacements and medically tailored meals in the treatment of obesity and related adiposity related complications.  Apply to use of meal replacements to patients with complicated medical diseases (heart failure, diabetes, kidney failure) and in various care settings (group homes, telemedicine, virtual groups, partial meal replacements and VLCD).

    Accreditation: 

    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Includes Credits

    Cate Varney, DO, ABOM

    CME/CE Expiration Date: 5/21/2025* 

    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

    Description: 

    In 2020, the U.S. Census Bureau released estimates showing the 65-and-older population has grown rapidly since 2010. The growth of this population contributed to an increase in the national median age from 37.2 years in 2010 to 38.4 in 2019. Within these numbers, women make up a majority percentage. This percentage only continues to grow as they age within this group. This is the fastest rising age group and obesity specialists must be prepared to take care of this population. Additionally, a growing number of patients are seeking bariatric surgery and there is known significant risk of weight gain following surgery.  As this post-bariatric surgery population ages, we must also understand how menopause will increase their risk of weight regain after loss.  With this knowledge, we can better assist our patients through all stages of their life with weight management.

    Accreditation: 

    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Includes Credits

    Louis Aronne, MD, FACP, DABOM

    CME/CE Expiration Date: 5/21/2025* 

    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

    Description: 

    Learning Objectives:

    1. Describe current metabolic targets of anti-obesity medications
    2. Identify key future metabolic targets of anti-obesity medications
    3. Discuss the status of promising future anti-obesity medications and their role in obesity treatment

    Accreditation: 

    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Includes Credits

    Jason Fung, MD

    CME/CE Expiration Date: 5/21/2025* 

    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

    Description: 

    This lecture focuses on the tight link between nutrition and cancer. It is estimated that about 30% of the risk of cancer can be attributed to diet, which is just below tobacco smoke and far, far above any other known risk factor. But what part of the diet is the culprit? For decades, the answer was unknown, but recent data from the last 20 years points directly to obesity and hyperinsulinemia as the primary culprit.

    Accreditation: 

    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Includes Credits

    Catherine Varney, DO, ABOM; Timothy Garvey MD, FACE, MABOM, Kenneth Resnicow PhD

    CME/CE Expiration Date: 5/21/2025* 

    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

    Description: 

    This session will have three presentations diving into a particular patient case. They will each focus on a separate complex case providing insight on how to handle and treat that unique patient.

    Accreditation: 

    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Includes Credits

    Carolynn Francavilla, MD

    CME/CE Expiration Date: 5/21/2025* 

    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

    Description: 

    The majority of women in the US will experience a pregnancy in their lifetime. Unfortunately, the treatment of obesity is, too often, not considered when preparing for and managing pregnancy or the postpartum period. In this lecture, we will discuss obesity treatment at various stages of a women’s reproductive life cycle.  We will explore the importance of obesity management at each stage and provide key recommendations.  We will discuss unique medication considerations, appropriate nutrition strategies, exercise guidelines, and special behavior change considerations. Participants will be able to apply practical strategies to treat women who are preparing for pregnancy, are pregnant, or are postpartum.

    Accreditation: 

    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Includes Credits

    Stephen Herrmann, PhD

    CME/CE Expiration Date: 5/21/2025* 

    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

    Description: 

    Many people who seek treatment for obesity are able to lose weight; however, far fewer are able to successfully sustain the behavior changes required to maintain results long term. Psychological resilience is an individual’s capacity to negotiate, manage, and adapt to significant sources of stress or “bounce back” when confronted with significant physical or emotional experiences. Assessing and improving resilience may provide new opportunities to improve patient adherence and long-term results.

    Accreditation: 

    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Includes Credits

    Stephen Herrmann, PhD

    CME/CE Expiration Date: 5/21/2025* 

    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

    Description: 

    Many people who seek treatment for obesity are able to lose weight; however, far fewer are able to successfully sustain the behavior changes required to maintain results long term. Psychological resilience is an individual’s capacity to negotiate, manage, and adapt to significant sources of stress or “bounce back” when confronted with significant physical or emotional experiences. Assessing and improving resilience may provide new opportunities to improve patient adherence and long-term results.

    Accreditation: 

    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Includes Credits

    Ganesh Shidham, MD

    CME/CE Expiration Date: 5/21/2025* 

    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

    Description: 

    Obesity and bariatric surgery are a risk factor for kidney stones and chronic kidney disease. Prevalence of kidney stones is higher amongst patients with obesity (11.2%) vs patients with normal weight (6.1%). Bariatric surgery is effective for weight loss, however bariatric surgery is associated with increased risk of kidney stones (HR 4.1) and CKD (HR 1.96).
    Because of the concurrent epidemics of obesity, metabolic syndrome, and diabetes (all independently associated with increased risks of stone formation), current projections estimate costs due to kidney stone disease to rise by $1.24 billion per year by 2030.
    The underlying mechanism for kidney stone formation in patients with obesity is thought to be due to insulin resistance, dietary factors and lithogenic urinary risk profile. Insulin resistance alters renal acid-base mechanism, resulting in acidic urine pH and thus increasing risk for uric acid stones. Obesity is also associated with excess nutritional intake of lithogenic substances promoting calcium Oxalate stones. In addition, patients with bariatric surgery are associated with significant hyperoxaluria leading to calcium oxalate stones and oxalate nephropathy leading to progressive chronic kidney disease, at times needing dialysi

    Accreditation: 

    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Claim credit for up to 12 CME/CE

    CME/CE Expiration Date:4/28/2025* 

    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

    Description: 

    Prepare for board certification in obesity medicine at the leading Review Course for the ABOM Exam! The Review Course offers a thorough review of the core content covered on the American Board of Obesity Medicine (ABOM) certification exam with a clinical focus – so you’re not only prepared to take the test, but you’re well equipped to deliver evidence-based care for your patients with obesity. The Review Course includes case-based questions during each session and during lighting round Q&A sessions at the end of each day.

    Accreditation: 

    The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. 

    The Obesity Medicine Association designates this live activity for a maximum of 12 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

  • Earn Unlimited CME for one year.

    All CME lectures available on the Academy are included in this package (over 400 hours of education).

    For one year, get access to 100% of the clinical content available on the Obesity Medicine Academy at an unbeatable discounted rate! Earn CME/CE credit and gain crucial knowledge and clinically applicable treatment strategies, all while learning from industry thought leaders, published journal authors, and your colleagues in the field of obesity medicine. 

  • 16.75 CME/CE

    CME/CE Expiration Date: 5/1/2025* 

    *The expiration date listed above is the last day CME/CE credit can be claimed for these specific presentations.

    Description:

    The Obesity Medicine Association Spring Conference will prepare you to treat obesity at the root to manage your patients’ obesity-related conditions and improve your patient’s overall health and quality of life. Gain practical strategies to address obesity in a primary care, specialty, or obesity medicine practice.

    Proficiency Track 

    Expand upon your foundational knowledge in obesity treatment and medicine. Sessions during this track will focus on the integration of skills in obesity medicine with an emphasis on practical treatment strategies, treating patients in special populations, and the essentials in obesity medicine. The Obesity Medicine 2022 Conference sessions during this track will focus on:

    • Essentials of anti-obesity medications
    • Treating obesity in special populations and how to appropriately modify your care
    • Understanding various nutritional diets and creating a personal meal plan for your patients
    • Emphasizing the role of physical activity in patients with obesity

    Accreditation:

    The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. 

    The Obesity Medicine Association designates this activity for a maximum of 16.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


  • Overcoming Obesity 2021- Fall Obesity Summit Pediatric Track (Recorded)

    CME/CE Expiration Date: 9/25/2024* 

    *The expiration date listed above is the last day CME/CE credit can be claimed for these specific presentations.

    Description:

    This education bundle features lectures on evidence-based treatment options for treating children and adolescents with obesity. These sessions will review the latest advancements in pharmacological and surgical interventions for treating adolescents with obesity, the role of physical activity in pediatric obesity management, and the impacts of social determinants of health, structural racisms, adverse childhood events (ACEs), and epigenetics on childhood obesity. 

    Accreditation:

    The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. 

    The Obesity Medicine Association designates this live activity for a maximum of 6 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

  • Claim credit for up to 12.5 CME/CE

    CME/CE Expiration Date: 9/24/2024* 

    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

    Description: 

    Prepare for board certification in obesity medicine at the leading Review Course for the ABOM Exam! The Review Course offers a thorough review of the core content covered on the American Board of Obesity Medicine (ABOM) certification exam with a clinical focus – so you’re not only prepared to take the test, but you’re well equipped to deliver evidence-based care for your patients with obesity. The Review Course includes case-based questions during each session and during lighting round Q&A sessions at the end of each day.

    Accreditation: 

    The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. 

    The Obesity Medicine Association designates this live activity for a maximum of 12.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

  • Claim credit for up to 16.75 CME/CE

    CME/CE Expiration Date: 9/26/2024* 

    *The expiration date listed above is the last day CME/CE credit can be claimed for these specific presentations.

    Description:

    The theme for the Fall Obesity Summit 2021 is Treat Obesity Across the Lifespan. Obesity is a diagnosis that is applied broadly, yet the disease of obesity is not the same in all populations. Age, gender, and socioeconomic status are among the many variables that influence obesity treatment.

    At the Fall Obesity Summit, receive advanced training on treating obesity in different populations and personalizing obesity treatment for each patient, including those who present with complex adiposity-related diseases. Discover existing and new medications that are currently or soon to become available for the treatment of obesity and obesity-related conditions. Understand how to choose and implement an individualized nutritional plan and the impact of various dietary interventions may on weight loss and diseases associated with obesity. Learn about how obesity affects a patient across their lifespan, and discover the latest innovations in the field of obesity medicine.

    Accreditation:

    The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. 

    The Obesity Medicine Association designates this live activity for a maximum of 16.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

  • CME/CE Expiration Date: 4/25/2024*

    CME/CE Expiration Date: 4/25/2024* 

    *The expiration date listed above is the last day CME/CE credit can be claimed for these specific presentations.

    Description: 

    Obesity prevalence is at worldwide epidemic levels, and behind cigarette smoking, obesity is the second leading cause of preventable deaths. Interventions directed toward improving nutrition, increasing physical activity, and changing eating behaviors can be effective treatments for obesity, but long -term benefits are often countered by neuro-hormonally activated homeostatic mechanisms that eventually lead to weight regain. Anti-obesity pharmacologic agents are often effective in combating the internal drives that increase appetite and contribute to obesity as well as those associated with weight regain. Despite the prevalence and deadly consequences of obesity, there are currently only four FDA approved anti-obesity medications for long -term use and four older sympathomimetic agents approved only three month’s treatment duration. Pharmacologic options for obesity treatment are further limited by other factors that include medication expense and lack of insurance coverage, concurrent medical conditions, drug interactions, adverse drug effects, and individual lack of therapeutic response in some individuals.  

    Fortunately, there are options that are not FDA approved (off-label) that are generally safe and efficacious for obesity treatment backed by clinical experience and medical literature. This educational series will focus on safe and efficacious obesity treatment in challenging patients when FDA approved therapeutic agents are not an option. 

    With disease management, the weight-gain potential of medications is often not considered when choosing pharmacotherapy options. Many commonly used medications associated with weight gain have alternatives with weight neutral or weight losing effects.  Shifting medication choices from weight positive to weight neutral or negative choices can be an effective means of facilitating weight loss. 

     

    Accreditation: 

    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this enduring material for a maximum of 3 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • CME/CE Expiration Date: 4/25/2024*

    CME/CE Expiration Date: 4/25/2024* 

    *The expiration date listed above is the last day CME/CE credit can be claimed for these specific presentations.

    Description: 

    The theme for the 2021 Spring Obesity Summit is Treat Obesity First. Obesity is associated with hundreds of other chronic diseases, so why not address it at the root? Treating obesity first will help you better manage obesity-related conditions; it will also reduce the risk of your patients developing further complications and improve their overall health and quality of life.

    At the Spring Obesity Summit, gain practical strategies you can use to address obesity at the root in a primary care, specialty, or obesity medicine practice. Learn how to apply evidence-based guidelines to the treatment of obesity – including selecting appropriate anti-obesity medications, managing patients in post-bariatric surgery, and treating your patients’ obesity-related conditions, including non-alcoholic fatty liver disease and cardiovascular disease. 

    Accreditation: 

    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this enduring material for a maximum of 22 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • CME/CE Expiration Date: 4/25/2024*

    CME/CE Expiration Date: 4/25/2024* 

    *The expiration date listed above is the last day CME/CE credit can be claimed for these specific presentations.

    Description: 

    Practice Management Essentials will focus on how to get started with an obesity medicine practice. The content is intended for physicians recently certified in obesity medicine, as well as other primary care or specialized physicians, NPs, and PAs who have the clinical obesity medicine knowledge but want to successfully set up an obesity medicine practice. 

     

    Accreditation: 

    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this enduring material for a maximum of 9.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.